Photodynamic Therapy of Actinic Keratoses With Alacare®

Completed

• Conditions: Actinic Keratosis

• Registration Number: NCT01571336
• Lead Sponsor: photonamic GmbH & Co. KG

Brief Summary

This study aims to collect data on the frequency of SCCs in the Alacare®-treated area during an interval of two years after Alacare®-PDT.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04
• Study First Submitted: 2012-04-03
• Study First Submitted QC: 2012-04-03
• Study First Posted: 2012-04-05
• Primary Completion: 2016-05
• Status Verified: 2016-09
• Study Completion: 2016-09
• Last Update Submitted: 2016-09-26
• Last Update Posted: 2016-09-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 388

Inclusion Criteria

• Written informed consent
• Patients with 3 to 6 mild AK lesions on the hairless areas of the head and face which were treated with Alacare®-PDT according to the SPC

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of SCCs in areas treated with Alacare®-PDT	Two years after Alacare®-PDT

Trial Locations

Locations (8)

Medizinisches Zentrum Bonn Friedensplatz; 🇩🇪 Bonn, Germany

Facharzt für Haut- und Geschlechtskrankheiten; 🇩🇪 Radolfzell, Germany

Gemeinschaftspraxis Dres.Ina Röhrig-Petering und Holger Petering; 🇩🇪 Hildesheim, Germany

Dermatologische Gemeinschaftspraxis Prof. Dr. J. Gille & Dr. K. Spieth-Gille; 🇩🇪 Königstein im Taunus, Germany

Hautarztpraxis Prof. Kurzen; 🇩🇪 Freising, Germany

ZENTderma; 🇩🇪 Mönchengladbach, Germany

Praxis Prof. Dr. Thomas Dirschka; 🇩🇪 Wuppertal, Germany

Hautärztliche Gemeinschaftspraxis Dr. med. Peter Dworzak Dr. med. Peter Radny; 🇩🇪 Friedrichshafen, Germany